Buyable Biotech? | CNBC

Positive data is made Isis Pharma's stock soar higher, but it's still down big for the year. Is now the time to get in? Jim Cramer gives his prognosis when he talks to its CEO. » Subscribe to CNBC: http://cnb.cx/SubscribeCNBC About: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more. Connect with CNBC News Online! Get the latest news: http://www.cnbc.com Find CNBC News on Facebook: http://cnb.cx/LikeCNBC Follow CNBC News on Twitter: http://cnb.cx/FollowCNBC Follow CNBC News on Google+: http://cnb.cx/PlusCNBC Follow CNBC News on Instagram: http://cnb.cx/InstagramCNBC Buyable Biotech? | CNBC